أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

mylan ab* - gabapentinum inn - hart hylki - 400 mg

الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

hansa biopharma ab - imlifidase - desensitization, immunologic; kidney transplantation - Ónæmisbælandi lyf - idefirix is indicated for desensitisation treatment of highly sensitised adult kidney transplant patients with positive crossmatch against an available deceased donor. the use of idefirix should be reserved for patients unlikely to be transplanted under the available kidney allocation system including prioritisation programmes for highly sensitised patients.

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

sandoz a/s* - gabapentinum inn - hart hylki - 300 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - gabapentinum inn - filmuhúðuð tafla - 600 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

upjohn eesv - gabapentinum inn - filmuhúðuð tafla - 800 mg

الاتحاد الأوروبي - الأيسلاندية - EMA (European Medicines Agency)

astrazeneca ab - tremelimumab - krabbamein, lungnakrabbamein - Æxlishemjandi lyf - tremelimumab astrazeneca in combination with durvalumab and platinum-based chemotherapy is indicated for the first-line treatment of adults with metastatic non-small cell lung cancer (nsclc) with no sensitising egfr mutations or alk positive mutations.

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

abcur ab - thiopentalum natricum inn - stungulyfsstofn, lausn - 1 g

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - gabapentinum inn - hart hylki - 400 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

alvogen ehf. - gabapentinum inn - hart hylki - 300 mg

أيسلندا - الأيسلاندية - LYFJASTOFNUN (Icelandic Medicines Agency)

stada arzneimittel ag - gabapentinum inn - hart hylki - 400 mg